Kuriakose Emil 4
4 · Terns Pharmaceuticals, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-30+485,000→ 485,000 totalExercise: $4.64Exp: 2035-01-29→ Common Stock (485,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.